Official announcements from Yap Inc. — partnerships, awards, funding, and more.
Press Release
Yap Signs Partnership Agreement with Italy's Icarus Technology
Yap Inc. has signed an official partnership agreement with Icarus Technology, a company based in Sardinia, Italy. The agreement follows business development meetings in Tokyo, supported by the Italian Trade Agency (ITA) Tokyo, the Tokyo Metropolitan Government, Tokyo Innovation Base, and Regione Autonoma della Sardegna. Icarus Technology provides a multilingual AI voice assistant that automates patient phone reception for clinics; together the two companies aim to combine this with Yap's healthcare business and AI capabilities to expand in the Japanese market.
Yap Signs Partnership Agreement with Indonesian Digital Biobank Asa Ren
Yap Inc. has signed a business partnership agreement with Asa Ren, an Indonesian digital biobank company. Asa Ren operates Southeast Asia's first AI-powered digital biobank, integrating clinical and genomic data across diverse ethnic groups to advance personalized medicine and drug discovery. The two companies aim to expand awareness and adoption of Asa Ren's digital biobank.
Yap Signs Import Agreement with Bangladesh's UniMed UniHealth — First Bangladeshi Pharma to Enter Japan
Yap Inc. has signed an import agreement with UniMed UniHealth Pharmaceuticals Limited of Bangladesh. The agreement marks the first entry of a Bangladeshi pharmaceutical company into the Japanese market, beginning with Novotin, a biotin-based nutritional supplement.
Healthcare commentary shared by CEO Masaya Yamamoto on NewsPicks.
Platform
Filter by Tag
NewsPicksJuly 29, 2026
社会保障138兆円 ― コスト削減より「医療需要を減らす投資」へ
More important than the headline figure of ¥138 trillion in social security spending is what lies beneath it. On top of natural growth driven by an aging population, rising medical costs from advanced treatments and high-priced drugs will keep upward pressure relentless. Simply cutting benefits or raising premiums cannot secure long-term sustainability, given the limits on the working-age population's burden. What is needed is a strategic shift toward investments that reduce medical demand in the first place—preventive care, extending healthy life expectancy, healthcare DX for efficiency gains, and preventing disease progression. Whether Japan can redesign social security not as a cost but as an investment in people is, I believe, a question directly tied to the country's broader competitiveness.
Social SecurityHealthcare DX & Preventive CareFiscal Sustainability
What ends this month is not the health insurance card itself, but the provisional measure that allowed expired cards to be accepted at medical institutions. From August onward, either a My Number health insurance card or a Certificate of Eligibility will be required. While online eligibility verification is taking hold in clinical settings—bringing real benefits such as prevention of duplicate prescriptions and better sharing of medical information—ongoing challenges remain: expired digital certificates, forgotten cards, and adequate support for elderly and digitally disadvantaged individuals. The success of this transition should be measured not by the My Number health insurance card adoption rate, but by whether the system can be operated in a way that leaves no one without access to medical care. Since a Certificate of Eligibility will be issued to those who choose not to use the My Number card, thorough public awareness of that option is also essential.
The fraudulent diversion of prescription drugs through the public assistance system is a serious issue that undermines trust in the program itself. At the same time, it would be counterproductive if such cases led to overly restrictive access for patients who genuinely need medication. What matters is not simply tightening the rules, but building a framework that uses data to detect high-risk prescription patterns at an early stage. If cross-sectional monitoring leveraging electronic prescriptions, My Number health insurance cards, and claims data moves forward, we can expect both deterrence of illicit diversion and proper medication use. What is needed is a collaborative structure involving healthcare, social welfare, and law enforcement—one that protects those who truly need support while precisely targeting and preventing abuse of the system.
Healthcare & PharmaceuticalsSocial Welfare PolicyDigital Health
The fact that 85% of support center counselors have witnessed secondary victimization reveals not isolated cases of misconduct, but a systemic and cultural problem that demands a fundamental rethink of how our support structures are designed. Survivors who must repeatedly recount their experiences across medical, law enforcement, and judicial institutions face an accumulating psychological toll—being disbelieved or subjected to repeated questioning discourages people from seeking help in the first place and has serious long-term consequences for mental health. Alongside better resource allocation to support centers, the immediate priority should be mandatory trauma-informed care training for staff across all relevant agencies and the establishment of integrated, one-stop coordination systems. It is only when the true severity of harm becomes visible that policy priorities can finally begin to shift.
Sexual Violence SupportTrauma-Informed CareSystemic Reform
This study challenges the simple equation of 'zero-calorie equals healthy.' Tracking approximately 13,000 participants over eight years, it found that high consumers of artificial sweeteners experienced cognitive decline 62% faster—though, as an observational study, causality remains unestablished. The key takeaway is not a binary choice between artificial sweeteners and sugar, but rather the need to reduce our overall dependence on sweetness itself. Food manufacturers are called upon to go beyond 'low-sugar' and 'low-calorie' labeling, designing formulations and communications that account for long-term health impacts.
Cognitive Health & Brain AgingFood & Nutrition ScienceHealthcare Policy
Napping is not merely rest—it is an effective means of restoring afternoon concentration and judgment. A short nap of around 20 to 30 minutes is generally thought to avoid deep sleep, suppress post-nap grogginess, and enhance cognitive function. That said, the finding that 'the brain ages six years more slowly' in nappers indicates an association, not a confirmed causal relationship. Because prolonged naps can interfere with nighttime sleep, corporate wellness programs should focus not simply on whether employees nap, but on thoughtfully designing the timing and duration of those naps.
Sleep & RestCognitive Function & Brain HealthCorporate Wellness